CN101785762B - 石杉碱甲口崩片及其制造方法 - Google Patents
石杉碱甲口崩片及其制造方法 Download PDFInfo
- Publication number
- CN101785762B CN101785762B CN 200910174864 CN200910174864A CN101785762B CN 101785762 B CN101785762 B CN 101785762B CN 200910174864 CN200910174864 CN 200910174864 CN 200910174864 A CN200910174864 A CN 200910174864A CN 101785762 B CN101785762 B CN 101785762B
- Authority
- CN
- China
- Prior art keywords
- huperzine
- ethanol
- orally disintegrating
- add
- disintegrating tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ZRJBHWIHUMBLCN-SEQYCRGISA-N Huperzine A Natural products N1C(=O)C=CC2=C1C[C@H]1/C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-SEQYCRGISA-N 0.000 title claims abstract description 72
- ZRJBHWIHUMBLCN-UHFFFAOYSA-N Shuangyiping Natural products N1C(=O)C=CC2=C1CC1C(=CC)C2(N)CC(C)=C1 ZRJBHWIHUMBLCN-UHFFFAOYSA-N 0.000 title claims abstract description 72
- ZRJBHWIHUMBLCN-YQEJDHNASA-N huperzine A Chemical compound N1C(=O)C=CC2=C1C[C@H]1\C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-YQEJDHNASA-N 0.000 title claims abstract description 72
- ZRJBHWIHUMBLCN-BMIGLBTASA-N rac-huperzine A Natural products N1C(=O)C=CC2=C1C[C@@H]1C(=CC)[C@@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-BMIGLBTASA-N 0.000 title claims abstract description 72
- 239000006191 orally-disintegrating tablet Substances 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 239000000203 mixture Substances 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 25
- 239000006185 dispersion Substances 0.000 claims abstract description 17
- 238000003756 stirring Methods 0.000 claims abstract description 17
- 238000001035 drying Methods 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 61
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 44
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 22
- 229930195725 Mannitol Natural products 0.000 claims description 22
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 22
- 235000019359 magnesium stearate Nutrition 0.000 claims description 22
- 239000000594 mannitol Substances 0.000 claims description 22
- 235000010355 mannitol Nutrition 0.000 claims description 22
- 229920002472 Starch Polymers 0.000 claims description 19
- 239000008107 starch Substances 0.000 claims description 19
- 235000019698 starch Nutrition 0.000 claims description 19
- 235000009508 confectionery Nutrition 0.000 claims description 18
- 239000008187 granular material Substances 0.000 claims description 13
- 239000012467 final product Substances 0.000 claims description 11
- 239000001856 Ethyl cellulose Substances 0.000 claims description 9
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 9
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 9
- 229920001249 ethyl cellulose Polymers 0.000 claims description 9
- 239000007921 spray Substances 0.000 claims description 9
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 6
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 6
- 229950005770 hyprolose Drugs 0.000 claims description 5
- 239000002002 slurry Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 11
- 239000002904 solvent Substances 0.000 abstract description 5
- 239000000314 lubricant Substances 0.000 abstract description 3
- 238000002844 melting Methods 0.000 abstract description 3
- 230000008018 melting Effects 0.000 abstract description 3
- 239000007767 bonding agent Substances 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 27
- 239000002671 adjuvant Substances 0.000 description 17
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 14
- 239000001768 carboxy methyl cellulose Substances 0.000 description 14
- 238000004132 cross linking Methods 0.000 description 14
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 14
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 9
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 9
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 9
- 239000000741 silica gel Substances 0.000 description 9
- 229910002027 silica gel Inorganic materials 0.000 description 9
- 239000003826 tablet Substances 0.000 description 8
- -1 polyoxyethylene stearate Polymers 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000007962 solid dispersion Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 238000007907 direct compression Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 108090000371 Esterases Proteins 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 229940100578 Acetylcholinesterase inhibitor Drugs 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241001090156 Huperzia serrata Species 0.000 description 1
- 239000005434 MCC/mannitol excipient Substances 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000032495 Phlegmariurus fordii Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910174864 CN101785762B (zh) | 2009-10-20 | 2009-10-20 | 石杉碱甲口崩片及其制造方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910174864 CN101785762B (zh) | 2009-10-20 | 2009-10-20 | 石杉碱甲口崩片及其制造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101785762A CN101785762A (zh) | 2010-07-28 |
CN101785762B true CN101785762B (zh) | 2013-04-24 |
Family
ID=42529240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910174864 Active CN101785762B (zh) | 2009-10-20 | 2009-10-20 | 石杉碱甲口崩片及其制造方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101785762B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1568985A (zh) * | 2003-07-21 | 2005-01-26 | 北京小伙伴医药生物技术有限公司 | 石杉碱甲口腔崩解片及其制备方法 |
CN1823769A (zh) * | 2005-12-23 | 2006-08-30 | 北京科信必成医药科技发展有限公司 | 石杉碱甲口腔崩解片及其制备方法 |
-
2009
- 2009-10-20 CN CN 200910174864 patent/CN101785762B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1568985A (zh) * | 2003-07-21 | 2005-01-26 | 北京小伙伴医药生物技术有限公司 | 石杉碱甲口腔崩解片及其制备方法 |
CN1823769A (zh) * | 2005-12-23 | 2006-08-30 | 北京科信必成医药科技发展有限公司 | 石杉碱甲口腔崩解片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101785762A (zh) | 2010-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100518746C (zh) | 冬虫夏草微粉片及其制备方法 | |
CN101708336B (zh) | 一种药用预混辅料 | |
CN101816637B (zh) | 来氟米特片制剂及其制备方法 | |
CN104688700A (zh) | 一种易于溶出的富马酸替诺福韦二吡呋酯片及其制备方法 | |
CN102137663A (zh) | 抑制变色的稳定的药物制剂 | |
CN109875972B (zh) | 一种奥美沙坦酯氨氯地平药物组合物 | |
CN101229141B (zh) | 一种阿司匹林缓释片及其制备方法 | |
CN106667936A (zh) | 一种索非布韦片剂及其制备方法 | |
CN104814923A (zh) | 一种盐酸坦洛新缓释制剂及其制备方法和其应用 | |
CN103301467A (zh) | 一种稳定的掩味的盐酸氨溴索复合物及其制备方法 | |
KR101086254B1 (ko) | 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법 | |
CN102727455B (zh) | 一种他达那非口腔崩解片及其制备方法 | |
CN101785762B (zh) | 石杉碱甲口崩片及其制造方法 | |
CN102008469B (zh) | 一种替米沙坦氨氯地平片的制备方法 | |
CN101804038A (zh) | 治疗精神分裂症及神经功能损伤用的石杉碱甲制剂及其制造方法 | |
CN102198107B (zh) | 拉西地平分散片及其制备方法 | |
CN115813866A (zh) | 一种枸橼酸西地那非口崩片及其生产制备方法 | |
CA2492156C (en) | Tablet composition containing kampo medicinal extract and its manufacturing process | |
CN101623317B (zh) | 千层塔口崩片及其制造方法 | |
CN102038642A (zh) | 一种银杏内酯b固体分散体及其制备方法 | |
CN101480482A (zh) | 一种牛黄降压口腔崩解片及其制备方法 | |
CN101890057A (zh) | 治疗胃肠道、泌尿道感染及心、脑血管疾病用的凤尾草制剂及其制备方法 | |
CN101658544B (zh) | 千层塔控释片及其制造方法 | |
CN100348180C (zh) | 盐酸曲马多口腔崩解片剂及其制备方法 | |
CN101658543A (zh) | 千层塔片及其制造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: XIE JINSHENG Owner name: ZHEJIANG WORLDBEST PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHAO SHOUMING Effective date: 20100806 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20100806 Address after: 317500 east of Zhejiang province Wenling city streets Baizhang Road No. 28 Applicant after: Zhejiang Worldbest Pharmaceutical Co., Ltd. Address before: 317500 east of Zhejiang province Wenling city streets Baizhang Road No. 28 Applicant before: Zhao Shouming Co-applicant before: Xie Jinsheng |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 317500 east of Zhejiang province Wenling city streets Baizhang Road No. 28 Applicant after: Zhejiang Wanbang Pharmaceutical Co., Ltd. Address before: 317500 east of Zhejiang province Wenling city streets Baizhang Road No. 28 Applicant before: Zhejiang Worldbest Pharmaceutical Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: ZHEJIANG WORLDBEST PHARMACEUTICAL CO., LTD. TO: ZHEJIANG WANBANG PHARMACEUTICAL CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: WANBANGDE PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: ZHEJIANG WANBANG PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 317500 east of Zhejiang province Wenling city streets Baizhang Road No. 28 Patentee after: WANBANGDE PHARMACEUTICAL GROUP CO., LTD. Address before: 317500 east of Zhejiang province Wenling city streets Baizhang Road No. 28 Patentee before: Zhejiang Wanbang Pharmaceutical Co., Ltd. |
|
CP03 | Change of name, title or address |
Address after: 317500, Zhejiang Province, Taizhou City, Wenling Province Street 28 North Zhang Road Patentee after: Wanbond Pharmaceutical Group Co., Ltd Address before: 317500, 28 North Road, Chengdong street, Zhejiang, Wenling Patentee before: ZHEJIANG WANBANG PHARMACEUTICAL PLC |
|
CP03 | Change of name, title or address |